Success Stories: EB-1A Petition Approved in 10 Days for Chinese Postdoctoral Associate in New York in the Field of Pharmaceutical Science
Client’s Testimonial:
“Thank you so much for your professional services in my case!!! If anybody I know wants to apply for Green card, I would like to recommend WeGreened to them.”
On March 21st, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Associate in the Field of Pharmaceutical Science (Approval Notice).
General Field: Pharmaceutical Science
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: New York
Approval Notice Date: March 21st, 2016
Processing Time: 10 Days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group (WeGreened.com) recently helped a postdoctoral associate from China attain an EB-1A (Alien of Extraordinary Ability) petition approval. Our client is immersed in the field of pharmaceutical science and has many years of experience studying targeted drug delivery with an emphasis on cancer and Alzheimer’s disease. As our client elected to file his case under Premium Processing, he received notification of case approval just 10 days after it was filed.
Client’s Credentials:
Our comprehensive EB-1A petition dossier was comprised of a wealth of information on our client’s various capabilities. For instance, we detailed his M.Sc. and Ph.D. in Pharmaceutics to prove to the USCIS that he possesses the ability to conduct outstanding research in his field. Additionally, we noted his 17 published papers and the 559 citations gathered from his work. To solidify our claim that our client is highly regarded by his peers, we listed the 32 times he assessed the work of other pharmaceutical scientists for various scientific journals.
Additional Evidence:
In an attempt to further fortify our EB-1A petition, we incorporated recommendation letters provided by other influential scientists in the field. We made certain that these recommenders were either affiliated with our client (dependent recommenders) or were familiar with his work through his publications (independent recommenders). The five signed letters that we received were just what we needed to prove to the USCIS that our client’s work is of value not just to the field, but to the United States as a whole—particularly the country’s medical sector. One of these letters stated “In all, [Client’s] accomplishments and contributions to medicine and pharmaceutics remove any doubt that his work should continue in the U.S. without interruption.”
Story of Success:
We congratulate our client for obtaining an EB-1A petition approval. We would like to thank him for selecting our law firm to represent his case, and we wish him well as he continues to investigate targeted drug delivery.